Global Immuno-Oncology Market Size, Status and Forecast 2021-2027

Global Immuno-Oncology Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2016-2027)
2.2 Immuno-Oncology Growth Trends by Regions
2.2.1 Immuno-Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immuno-Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Immuno-Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Immuno-Oncology Industry Dynamic
2.3.1 Immuno-Oncology Market Trends
2.3.2 Immuno-Oncology Market Drivers
2.3.3 Immuno-Oncology Market Challenges
2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Revenue
3.1.1 Global Top Immuno-Oncology Players by Revenue (2016-2021)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Revenue
3.4 Global Immuno-Oncology Market Concentration Ratio
3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2020
3.5 Immuno-Oncology Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
4.1 Global Immuno-Oncology Historic Market Size by Type (2016-2021)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2022-2027)
5 Immuno-Oncology Breakdown Data by Application
5.1 Global Immuno-Oncology Historic Market Size by Application (2016-2021)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immuno-Oncology Market Size (2016-2027)
6.2 North America Immuno-Oncology Market Size by Type
6.2.1 North America Immuno-Oncology Market Size by Type (2016-2021)
6.2.2 North America Immuno-Oncology Market Size by Type (2022-2027)
6.2.3 North America Immuno-Oncology Market Size by Type (2016-2027)
6.3 North America Immuno-Oncology Market Size by Application
6.3.1 North America Immuno-Oncology Market Size by Application (2016-2021)
6.3.2 North America Immuno-Oncology Market Size by Application (2022-2027)
6.3.3 North America Immuno-Oncology Market Size by Application (2016-2027)
6.4 North America Immuno-Oncology Market Size by Country
6.4.1 North America Immuno-Oncology Market Size by Country (2016-2021)
6.4.2 North America Immuno-Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size (2016-2027)
7.2 Europe Immuno-Oncology Market Size by Type
7.2.1 Europe Immuno-Oncology Market Size by Type (2016-2021)
7.2.2 Europe Immuno-Oncology Market Size by Type (2022-2027)
7.2.3 Europe Immuno-Oncology Market Size by Type (2016-2027)
7.3 Europe Immuno-Oncology Market Size by Application
7.3.1 Europe Immuno-Oncology Market Size by Application (2016-2021)
7.3.2 Europe Immuno-Oncology Market Size by Application (2022-2027)
7.3.3 Europe Immuno-Oncology Market Size by Application (2016-2027)
7.4 Europe Immuno-Oncology Market Size by Country
7.4.1 Europe Immuno-Oncology Market Size by Country (2016-2021)
7.4.2 Europe Immuno-Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Market Size (2016-2027)
8.2 Asia-Pacific Immuno-Oncology Market Size by Type
8.2.1 Asia-Pacific Immuno-Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immuno-Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immuno-Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Immuno-Oncology Market Size by Application
8.3.1 Asia-Pacific Immuno-Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immuno-Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immuno-Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Immuno-Oncology Market Size by Region
8.4.1 Asia-Pacific Immuno-Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immuno-Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Market Size (2016-2027)
9.2 Latin America Immuno-Oncology Market Size by Type
9.2.1 Latin America Immuno-Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Immuno-Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Immuno-Oncology Market Size by Type (2016-2027)
9.3 Latin America Immuno-Oncology Market Size by Application
9.3.1 Latin America Immuno-Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Immuno-Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Immuno-Oncology Market Size by Application (2016-2027)
9.4 Latin America Immuno-Oncology Market Size by Country
9.4.1 Latin America Immuno-Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Immuno-Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Market Size (2016-2027)
10.2 Middle East & Africa Immuno-Oncology Market Size by Type
10.2.1 Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immuno-Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immuno-Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Immuno-Oncology Market Size by Application
10.3.1 Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immuno-Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immuno-Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Immuno-Oncology Market Size by Country
10.4.1 Middle East & Africa Immuno-Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immuno-Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2016-2021)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Details
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Immuno-Oncology Introduction
11.3.4 Roche AG Revenue in Immuno-Oncology Business (2016-2021)
11.3.5 Roche AG Recent Development
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Details
11.4.2 AstraZeneca, Plc Business Overview
11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2016-2021)
11.4.5 AstraZeneca, Plc Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Immuno-Oncology Introduction
11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2016-2021)
11.5.5 Sanofi S.A. Recent Development
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Details
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2016-2021)
11.6.5 Dendreon Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Immuno-Oncology Introduction
11.7.4 Novartis Revenue in Immuno-Oncology Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Details
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2016-2021)
11.8.5 Gilead Sciences Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Immuno-Oncology Introduction
11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2016-2021)
11.9.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Cytokine-Based Immunotherapy
Table 4. Key Players of Cancer Vaccines
Table 5. Key Players of CAR-T Cell Therapy
Table 6. Key Players of Others
Table 7. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immuno-Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Immuno-Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Immuno-Oncology Market Share by Regions (2016-2021)
Table 11. Global Immuno-Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Immuno-Oncology Market Share by Regions (2022-2027)
Table 13. Immuno-Oncology Market Trends
Table 14. Immuno-Oncology Market Drivers
Table 15. Immuno-Oncology Market Challenges
Table 16. Immuno-Oncology Market Restraints
Table 17. Global Immuno-Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Immuno-Oncology Market Share by Players (2016-2021)
Table 19. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology as of 2020)
Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Immuno-Oncology Revenue Market Share by Type (2016-2021)
Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Immuno-Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Immuno-Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Immuno-Oncology Revenue Market Share by Application (2016-2021)
Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Immuno-Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Immuno-Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Immuno-Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Immuno-Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Immuno-Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Immuno-Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Immuno-Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Immuno-Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Immuno-Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Immuno-Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Immuno-Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Immuno-Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Immuno-Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Immuno-Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Immuno-Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Immuno-Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Immuno-Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Immuno-Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Immuno-Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Immuno-Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Immuno-Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Details
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Immuno-Oncology Product
Table 67. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Merck & Co., Inc. Company Details
Table 70. Merck & Co., Inc. Business Overview
Table 71. Merck & Co., Inc. Immuno-Oncology Product
Table 72. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 73. Merck & Co., Inc. Recent Development
Table 74. Roche AG Company Details
Table 75. Roche AG Business Overview
Table 76. Roche AG Immuno-Oncology Product
Table 77. Roche AG Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 78. Roche AG Recent Development
Table 79. AstraZeneca, Plc Company Details
Table 80. AstraZeneca, Plc Business Overview
Table 81. AstraZeneca, Plc Immuno-Oncology Product
Table 82. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 83. AstraZeneca, Plc Recent Development
Table 84. Sanofi S.A. Company Details
Table 85. Sanofi S.A. Business Overview
Table 86. Sanofi S.A. Immuno-Oncology Product
Table 87. Sanofi S.A. Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 88. Sanofi S.A. Recent Development
Table 89. Dendreon Pharmaceuticals Company Details
Table 90. Dendreon Pharmaceuticals Business Overview
Table 91. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 92. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 93. Dendreon Pharmaceuticals Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Immuno-Oncology Product
Table 97. Novartis Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Gilead Sciences Inc. Company Details
Table 100. Gilead Sciences Inc. Business Overview
Table 101. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 102. Gilead Sciences Inc. Recent Development
Table 103. Merck KGaA Company Details
Table 104. Merck KGaA Business Overview
Table 105. Merck KGaA Immuno-Oncology Product
Table 106. Merck KGaA Revenue in Immuno-Oncology Business (2016-2021) & (US$ Million)
Table 107. Merck KGaA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Market Share by Type: 2020 VS 2027
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Cytokine-Based Immunotherapy Features
Figure 4. Cancer Vaccines Features
Figure 5. CAR-T Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Immuno-Oncology Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Report Years Considered
Figure 12. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Immuno-Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Immuno-Oncology Market Share by Regions: 2020 VS 2027
Figure 15. Global Immuno-Oncology Market Share by Regions (2022-2027)
Figure 16. Global Immuno-Oncology Market Share by Players in 2020
Figure 17. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2020
Figure 19. Global Immuno-Oncology Revenue Market Share by Type (2016-2021)
Figure 20. Global Immuno-Oncology Revenue Market Share by Type (2022-2027)
Figure 21. North America Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Immuno-Oncology Market Share by Type (2016-2027)
Figure 23. North America Immuno-Oncology Market Share by Application (2016-2027)
Figure 24. North America Immuno-Oncology Market Share by Country (2016-2027)
Figure 25. United States Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Immuno-Oncology Market Share by Type (2016-2027)
Figure 29. Europe Immuno-Oncology Market Share by Application (2016-2027)
Figure 30. Europe Immuno-Oncology Market Share by Country (2016-2027)
Figure 31. Germany Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Immuno-Oncology Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Immuno-Oncology Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Immuno-Oncology Market Share by Region (2016-2027)
Figure 41. China Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Immuno-Oncology Market Share by Type (2016-2027)
Figure 49. Latin America Immuno-Oncology Market Share by Application (2016-2027)
Figure 50. Latin America Immuno-Oncology Market Share by Country (2016-2027)
Figure 51. Mexico Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Immuno-Oncology Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Immuno-Oncology Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Immuno-Oncology Market Share by Country (2016-2027)
Figure 57. Turkey Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Immuno-Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 61. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 62. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 63. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 64. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 65. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 67. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 68. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs